← SynDRA
BATOPROTAFIB
SynDRA canonical compound SYN0040196 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | PTPN11 |
|---|
| Mechanism of action | tyrosine phosphatase inhibitor |
|---|
| Indication | colorectal cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- PTPN11 INHIBITOR
- Protein-tyrosine phosphatase 2C inhibitor
- tyrosine phosphatase inhibitor
Cross-references
Synonyms
- PTPN11 INHIBITOR TNO155
- SHP2 INHIBITOR TNO155
- TNO-155
- TNO155
- Tno 155
- compound 1 [PMID: 32910655]
- compound 1 (PMID: 32910655)
- RefChem:116662
- FPJWORQEGI
- SHP2 inhibitor TNO155
- PTPN11 inhibitor TNO155
- MFCD32693919
- C18H24ClN7OS
- Batoprotafib [INN]
- UNII-FPJWORQEGI
- orb1309000
- SCHEMBL16914359
- SCHEMBL29361190
- SCHEMBL29827911
- TNO 155 [WHO-DD]
- GTPL12068
- TNO155?
- YQF2767
- GLXC-22546
- EX-A3645
- BDBM50553783
- NSC825523
- AKOS040740434
- EBC-470111
- NSC-825523
- NCGC00846667-01
- AC-36494
- MS-27407
- DB-130941
- HY-136173
- CS-0120271
- D81634
- T13176
- F980851
Look up BATOPROTAFIB in the interactive SynDRA portal →